alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › precision-medicine

precision-medicine

4 studies tagged precision-medicine, dated 2018-12-27 to 2024-02-23. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. New precision medicine avenues to the prevention of Alzheimer's disease from insights into the structure and function of γ-secretases 2024-02-23
  2. Precision medicine analysis of heterogeneity in individual-level treatment response to amyloid beta removal in early Alzheimer's disease 2023-10-26
  3. Precision Medicine for Preventing Alzheimer's Disease: Analysis of the ADAPT Study 2023-01-01

Studies

4 studies carry this tag.

Date range

2018 to 2024

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Journal of Alzheimer's disease : JAD 1
  • Neuron 1
  • The EMBO journal 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. New precision medicine avenues to the prevention of Alzheimer's disease from insights into the structure and function of γ-secretases

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. The EMBO journal 2024-02-23 Treatments

    Two phase-III clinical trials with anti-amyloid peptide antibodies have met their primary goal, i.e. slowing of Alzheimer's disease (AD) progression.

  2. Precision medicine analysis of heterogeneity in individual-level treatment response to amyloid beta removal in early Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-10-26 Biomarkers

    This ITR analysis provides a proof of concept for precision medicine in future AD research and drug development.

  3. Precision Medicine for Preventing Alzheimer's Disease: Analysis of the ADAPT Study

    ✓ Peer-reviewed alzhub usefulness score 74 out of 100. Journal of Alzheimer's disease : JAD 2023-01-01 Biomarkers

    The current results provide additional support for a precision medicine model for treating and preventing Alzheimer's disease.

  4. Harnessing Genetic Complexity to Enhance Translatability of Alzheimer's Disease Mouse Models: A Path toward Precision Medicine

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Neuron 2018-12-27 Genetics

    An individual's genetic makeup plays a large role in determining susceptibility to Alzheimer's disease (AD) but has largely been ignored in preclinical studies.

All topic tags with their study counts